JAMA Network Home
Sign In
Research Letter

Immune Checkpoint Inhibitors as Independent and Synergistic Drivers of SJS/TEN

JAMA Oncology 10.1001/jamaoncol.2025.4349

October 30, 2025 at 11:00 AM EDT

Read the full article

This cross-sectional study examines the association of immune checkpoint inhibitor use with Stevens-Johnson syndrome, toxic epidermal necrolysis.

Corresponding Author: Elizabeth Phillips, MD, Vanderbilt University Medical Center, 1211 Medical Center Dr, Nashville, TN 37232 (elizabeth.j.phillips@vumc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.4349?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=103025

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks